Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes

Human Immunology

Volumn 72, Issue 11, 2011, Pages 1013-1017

  Pillet, Anne Hélène ^a   Thèze, Jacques ^a   Rose, Thierry ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Cell activation; Cytokine; Cytokine receptors; Interleukin; Natural killer cells

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR GAMMA; PROTEIN BCL 2; STAT5 PROTEIN;

ARTICLE; CELL ACTIVATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

CELLS, CULTURED; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TIME FACTORS;

EID: 80054091086     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.07.311     Document Type: Article

References (29)

1. Becknell B., Caligiuri M.A. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv Immunol 2005, 86:209-239.
2. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989, 47:187-376.
3. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat Immunol 2008, 9:503-510.
4. Waldmann T.A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 2006, 6:595-601.
5. Leclercq G., Debacker V., de Smedt M., Plum J. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J Exp Med 1996, 184:325-336.
6. Chiossone L., Vitale C., Cottalasso F., Moretti S., Azzarone B., Moretta L., et al. Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells. Blood 2007, 109:3767-3775.
7. high T cells and its antitumor action. J Immunol 2008, 180:2099-2106.
8. Ma A., Koka R., Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 2006, 24:657-679.
9. Sun R., Fan J., Wei H., Zhang C., Tian Z. Use of interleukin-15 for preparation of adherent NK cells from human peripheral blood: comparison with interleukin-2. J Immunol Methods 2003, 279:79-90.
10. Pillet A.H., Bugault F., Thèze J., Chakrabarti L.A., Rose T. A programmed switch from IL-15- to IL-2-dependent activation in human NK cells. J Immunol 2009, 182:6267-6277.
11. Pillet A.H., Lavergne V., Gesbert F., Mazard-Pasquier V., Theze J., Rose T. IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork. J Mol Biol 2010, 403:671-692.
12. Eckenberg R., Rose T., Moreau J.L., Weil R., Gesbert F., Dubois S., et al. The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells. J Exp Med 2000, 191:529-540.
13. Pillet A.H., Juffroy O., Mazard-Pasquier V., Moreau J.L., Gesbert F., Chastagner P., et al. Human IL-Rbeta chains form IL-2 binding homodimers. Eur Cytokine Netw 2008, 19:49-59.
14. Rose T., Moreau J.L., Eckenberg R., Thèze J. Structural analysis and modeling of a synthetic interleukin-2 mimetic and its interleukin-2Rbeta2 receptor. J Biol Chem 2003, 278:22868-22876.
15. David D., Bani L., Moreau J.L., Demaison C., Sun K., Salvucci O., et al. Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets. Blood 1998, 91:165-172.
16. Ellery J.M., Nicholls P.J. Alternate signalling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev 2002, 13:27-40.
17. Gu H., Maeda H., Moon J.J., Lord J.D., Yoakim M., Nelson B.H., et al. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol Cell Biol 2000, 20:7109-7120.
18. Hunt A.E., Lali F.V., Lord J.D., Nelson B.H., Miyazaki T., Tracey K.J., et al. Role of interleukin (IL)-2 receptor beta-chain subdomains and Shc in p38 mitogen-activated protein (MAP) kinase and p54 MAP kinase (stress-activated protein kinase/c-Jun N-terminal kinase) activation. IL-2-driven proliferation is independent of p38 and p54 MAP kinase activation. J Biol Chem 1999, 274:7591-7597.
19. Leonard W.J. Role of Jak kinases and STATs in cytokine signal transduction. Int J Hematol 2001, 73:271-277.
20. DiSanto J.P. Cytokines: shared receptors, distinct functions. Curr Biol 1997, 7:R424-R426.
21. Ma A., Boone D.L., Lodolce J.P. The pleiotropic functions of interleukin 15: not so interleukin 2-like after all. J Exp Med 2000, 191:753-756.
22. Waldmann T.A., Dubois S., Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001, 14:105-110.
23. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
24. Rose T., Lambotte O., Pallier C., Delfraissy J.F., Colle J.H. Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients. J Immunol 2009, 182:7389-7397.
25. Kumar A., Moreau J.L., Gibert M., Thèze J. Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines. J Immunol 1987, 139:3680-3684.
26. Bani L., David D., Février M., Pialoux G., Dupont B., Sugamura K., et al. Interleukin-2 receptor beta and gamma chain dysregulation during the inhibition of CD4 T cell activation by human immunodeficiency virus-1 gp120. Eur J Immunol 1997, 27:2188-2194.
27. Bani L., Pasquier V., Kryworuchko M., Salamero J., Thèze J. Unstimulated human CD4 lymphocytes express a cytoplasmic immature form of the common cytokine receptor gamma-chain. J Immunol 2001, 167:344-349.
28. Noguchi M., Sarin A., Aman M.J., Nakajima H., Shores E.W., Henkart P.A., et al. Functional cleavage of the common cytokine receptor gamma chain (γc) by calpain. Proc Natl Acad Sci U S A 1997, 94:11534-11539.
29. Burmeister Y., Lischke T., Dahler A.C., Mages H.W., Lam K.P., Coyle A.J., et al. ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol 2008, 180:774-782.